Agios to Webcast Conference Call of Third Quarter 2020 Financial Results on November 5, 2020

Rhea-AI Summary

Agios Pharmaceuticals (NASDAQ: AGIO) will hold a conference call on November 5, 2020, at 8:00 a.m. ET to discuss its third quarter 2020 financial results and business highlights. Interested parties can access the live webcast via the company's website or join by phone. Agios focuses on developing innovative treatments for cancer and rare genetic diseases, boasting two approved oncology medicines and a robust pipeline of investigational therapies.

Positive

• Agios has two approved oncology precision medicines.
• The company has multiple first-in-class investigational therapies in clinical and preclinical development.

Negative

• None.

CAMBRIDGE, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company will host a conference call and live webcast on Thursday, November 5, 2020 at 8:00 a.m. ET to report its third quarter 2020 financial results and other business highlights.

A live webcast can be accessed under "Events & Presentations" in the Investors section of the company's website at www.agios.com. The conference call can be accessed by dialing 1-877-377-7098 (domestic) or 1-631-291-4547 (international) and referring to conference ID 7578909. The webcast will be archived and made available for replay on the company's website beginning approximately two hours after the event.

About Agios
Agios is focused on discovering and developing novel investigational medicines to treat malignant hematology, solid tumors and rare genetic diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across these three therapeutic areas, Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development. For more information, please visit the company's website at www.agios.com. 

Contacts

Investors:
Holly Manning, 617-844-6630
Director, Investor Relations
Holly.Manning@agios.com

Media:
Jessica Rennekamp, 857-209-3286
Associate Director, Corporate Communications
Jessica.Rennekamp@agios.com

FAQ

When will Agios Pharmaceuticals report its third quarter 2020 financial results?

Agios Pharmaceuticals will report its third quarter 2020 financial results on November 5, 2020, at 8:00 a.m. ET.

How can I access the Agios Pharmaceuticals conference call?

You can access the Agios Pharmaceuticals conference call by dialing 1-877-377-7098 for domestic calls or 1-631-291-4547 for international calls, using conference ID 7578909.

What is the focus of Agios Pharmaceuticals?

Agios Pharmaceuticals focuses on discovering and developing novel medicines to treat cancer and rare genetic diseases.

Where can I find more information about Agios Pharmaceuticals?

More information about Agios Pharmaceuticals can be found on their website at www.agios.com.